Cargando…

Neuroprotective and neurorestorative potential of xenon

Detalles Bibliográficos
Autores principales:	Lavaur, J, Lemaire, M, Pype, J, Le Nogue, D, Hirsch, E C, Michel, P P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	News and Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855665/ https://www.ncbi.nlm.nih.gov/pubmed/27054337 http://dx.doi.org/10.1038/cddis.2016.86

Ejemplares similares

Xenon-mediated neuroprotection in response to sustained, low-level excitotoxic stress
por: Lavaur, J, et al.
Publicado: (2016)

The noble gas xenon provides protection and trophic stimulation to midbrain dopamine neurons
por: Lavaur, Jérémie, et al.
Publicado: (2017)

Neuroprotection of dopamine neurons by xenon against low-level excitotoxic insults is not reproduced by other noble gases
por: Le Nogue, Déborah, et al.
Publicado: (2019)

Natural Products for the Potential Use of Neuroprotective and Neurorestorative Effects in Stroke
por: Chen, Hansen, et al.
Publicado: (2023)

Stem Cell-Based Neuroprotective and Neurorestorative Strategies
por: Hung, Chia-Wei, et al.
Publicado: (2010)

Antiapoptotic activity of argon and xenon
por: Spaggiari, Sabrina, et al.
Publicado: (2013)

Neurorestorative Therapy for Stroke
por: Chen, Jieli, et al.
Publicado: (2014)

Neuroprotective and Neurorestorative Processes after Spinal Cord Injury: The Case of the Bulbospinal Respiratory Neurons
por: Kastner, Anne, et al.
Publicado: (2016)

Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?
por: Youdim, Moussa B. H.
Publicado: (2010)

Neurorestoration Approach by Biomaterials in Ischemic Stroke
por: Esteban-Garcia, Noelia, et al.
Publicado: (2020)

XENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia
por: Esencan, Ecem, et al.
Publicado: (2013)

Noble Gas (Argon and Xenon)-Saturated Cold Storage Solutions Reduce Ischemia-Reperfusion Injury in a Rat Model of Renal Transplantation
por: Irani, Y., et al.
Publicado: (2012)

A neurorestorative approach to Parkinson's disease
por: Diana, Giovanni, et al.
Publicado: (2017)

Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Diseases as Disease Modifying Agents
por: Youdim, Moussa B. H.
Publicado: (2010)

Neuroprotective and Neurorestorative Effects of Holothuria scabra Extract in the MPTP/MPP(+)-Induced Mouse and Cellular Models of Parkinson’s Disease
por: Noonong, Kunwadee, et al.
Publicado: (2020)

Neuroprotection in Glaucoma
por: Nilforushan, Naveed
Publicado: (2012)

Adult Neurogenesis and Gliogenesis: Possible Mechanisms for Neurorestoration
por: Rusznák, Zoltán, et al.
Publicado: (2016)

Multi Target Neuroprotective and Neurorestorative Anti-Parkinson and Anti-Alzheimer Drugs Ladostigil and M30 Derived from Rasagiline
por: Youdim, Moussa B.H.
Publicado: (2013)

Iron and zinc: Nutrients with potential for neurorestoration in premature infants with cerebral white matter injury
por: Volpe, Joseph J.
Publicado: (2020)

Can Ultrasound-Guided Xenon Delivery Provide Neuroprotection in Traumatic Brain Injury?
por: Hwang, Misun, et al.
Publicado: (2022)

How Wld(S) neuroprotects
por: Williams, Ruth
Publicado: (2009)

Neurorestoration Induced by Mesenchymal Stem Cells: Potential Therapeutic Mechanisms for Clinical Trials
por: Seo, Jung Hwa, et al.
Publicado: (2012)

Adult Neural Stem Cells: Basic Research and Production Strategies for Neurorestorative Therapy
por: Samoilova, E. M., et al.
Publicado: (2018)

First Xenon-Xenon Collisions in the LHC
por: Schaumann, Michaela, et al.
Publicado: (2018)

Xenon-Xenon collision events in CMS
por: Mc Cauley, Thomas, et al.
Publicado: (2017)

The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist
por: Gassaway, M M, et al.
Publicado: (2014)

Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for traumatic brain injury via neuroprotection and neurorestoration
por: Xiong, Ye, et al.
Publicado: (2023)

Immunomodulators and microRNAs as neurorestorative therapy for ischemic stroke
por: Martinez, Bridget, et al.
Publicado: (2017)

XENON
por: Aprile, Elena
Publicado: (2011)

αTAT1: a potential therapeutic target in cancer?
por: Chien, J-Y, et al.
Publicado: (2016)

Histamine: a potential cytoprotective agent to improve cancer therapy?
por: Martinel Lamas, D J, et al.
Publicado: (2015)

The cellular mechanisms associated with the anesthetic and neuroprotective properties of xenon: a systematic review of the preclinical literature
por: McGuigan, Steven, et al.
Publicado: (2023)

Correction for the article “Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?” by Moussa B. H. Youdim
Publicado: (2015)

Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)
por: Huang, Hongyun, et al.
Publicado: (2018)

An homeopathic cure to pure Xenon large diffusion
por: Azevedo, C.D.R., et al.
Publicado: (2015)

Xenon Combined with Therapeutic Hypothermia Is Not Neuroprotective after Severe Hypoxia-Ischemia in Neonatal Rats
por: Sabir, Hemmen, et al.
Publicado: (2016)

Kathodolumineszenz kondensierten Xenons
por: Bogdankevich, O V, et al.
Publicado: (1970)

ROCKing Regeneration: Rho Kinase Inhibition as Molecular Target for Neurorestoration
por: Tönges, Lars, et al.
Publicado: (2011)

Neurorestoration from medicinal plants: an opportunity to treat painful neuropathies
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2017)

Recent Advances in Nanomaterials for Diagnosis, Treatments, and Neurorestoration in Ischemic Stroke
por: Lin, Xinru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q7mipttv5n9v863lh31utpb3gm